Health Bulletin Haiti: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Bulletin Haiti.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on December 17, 2025

Dec. 17, 2025

Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection

GlobeNewswire

Dec. 17, 2025

UCB’s Bimzelx Continues to Shift Biologic Treatment Patterns in Hidradenitis Suppurativa as Demand for Innovation Grows, According to Spherix Global Insights

GlobeNewswire

Dec. 17, 2025

Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted Chemotherapy

GlobeNewswire

Dec. 17, 2025

PCCA Partners with Pillumina® to Advance Environmental Sustainability in Compounding with Aluminum Pill Bottles

GlobeNewswire

Dec. 17, 2025

Tiziana Life Sciences to Ring the Closing Bell at Nasdaq

GlobeNewswire

Dec. 17, 2025

UPDATE -- Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast

GlobeNewswire

Dec. 17, 2025

Acentra Health Appoints President and Chief Operations Officer Meghan Harris to Its Board of Directors

GlobeNewswire

Dec. 17, 2025

Kyverna Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock

GlobeNewswire

Dec. 17, 2025

Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment

GlobeNewswire

Dec. 17, 2025

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

GlobeNewswire

Dec. 17, 2025

SafeSpace Global Corporation (OTCID: SSGC) Appoints Harvest Communications as Investor Relations and Corporate Communications Consulting Agency

GlobeNewswire

Dec. 17, 2025

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy

GlobeNewswire

Dec. 17, 2025

Population Health Partners and dacadoo Announce Strategic Partnership to Advance Digital Health Engagement and Outcome-Based Healthcare

GlobeNewswire

Dec. 17, 2025

Incyclix Bio Expands Board of Directors with Appointment of Dr. Kimberly Blackwell

GlobeNewswire

Dec. 17, 2025

Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare

GlobeNewswire

Dec. 17, 2025

INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”

GlobeNewswire

Dec. 17, 2025

Cadrenal Therapeutics to Conduct Partnering and Investor Meetings During the J.P. Morgan 44th Annual Healthcare Conference in San Francisco on January 12-15, 2026

GlobeNewswire

Dec. 17, 2025

Alira Health Appoints Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador

GlobeNewswire

Dec. 17, 2025

Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial

GlobeNewswire

Dec. 17, 2025

Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors

GlobeNewswire